Clarity Pharmaceuticals Ltd
ASX:CU6
Clarity Pharmaceuticals Ltd
Cash from Financing Activities
Clarity Pharmaceuticals Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Financing Activities
AU$231.6k
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Financing Activities
-AU$431.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Financing Activities
AU$3.6m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-18%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Financing Activities
AU$36.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
46%
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Financing Activities
-AU$11.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
Arovella Therapeutics Ltd
ASX:ALA
|
Cash from Financing Activities
AU$5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
93%
|
CAGR 10-Years
N/A
|
See Also
What is Clarity Pharmaceuticals Ltd's Cash from Financing Activities?
Cash from Financing Activities
231.6k
AUD
Based on the financial report for Jun 30, 2023, Clarity Pharmaceuticals Ltd's Cash from Financing Activities amounts to 231.6k AUD.
What is Clarity Pharmaceuticals Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-70%
Over the last year, the Cash from Financing Activities growth was -100%. The average annual Cash from Financing Activities growth rates for Clarity Pharmaceuticals Ltd have been -70% over the past three years .